News
Advancements in HIV treatment allowed him to celebrate his 62nd birthday in June. But he's worried with HIV prevention and ...
A man has denied multiple counts of rape and intentionally transmitting HIV to other men.Adam Hall, 42, of Donvale Road, ...
A recent study shows a substantial decline in the use of nonrecommended antiviral prescriptions among Medicare beneficiaries ...
The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...
Analysis shows Gilead’s recently approved drug for HIV prevention, Yeztugo, has the potential to transform the PrEP sector in the US.
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
23h
News-Medical.Net on MSNHIV treatment linked to risk of early knee osteoarthritisAcquired immune deficiency syndrome, or AIDS, caused by the human immunodeficiency virus (HIV), weakens the body's immune ...
Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say about it.
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...
Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...
Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results